Utah has become the first US state to allow an AI chatbot called Doctronic to renew prescriptions without a doctor, operating through a regulatory sandbox that waives standard licensing laws. The state's medical licensing board, which was not consulted before the January launch, issued an April letter calling for the pilot to be halted over safety concerns including auto-renewal of high-risk drugs like blood thinners. The state refused to suspend the program, noting human doctors still review refills in this phase, though fully automated refills are planned. The case highlights a regulatory vacuum: medical technology falls under federal jurisdiction while medical professionals are state-regulated, and Doctronic has not disclosed whether it sought FDA approval. Critics compare the moment to the unregulated medicine of the early 20th century, warning that AI chatbots can sound authoritative while dispensing dangerous advice.
